Connect with us
Gilead’s upcoming development plan for Assembly Biosciences’ HSV drugs could reshape the herpes market. ABI-5366 and ABI-1179 have shown strong antiviral results and may form a...
Galicia has approved its Biotechnology Strategy 2026–2030, mobilizing €805 million to boost competitiveness. The plan prioritizes health, agri-food, and advanced technologies, including the 1HealthAI hub. It...
Gene therapies are transforming rare disease treatment, enabling normal lives for some patients. However, only about 6% of 7,000 rare diseases have treatments. Advances show curative...
Bavaria’s biotech sector grew in 2025, with companies rising 1.5% to 548 and funding exceeding €930 million. Startups surged, with 26 new firms. Employment reached 59,000....
AseBio presented its 2025 report on the Biotech Act, highlighting opportunities for Spanish biotechnology while urging greater ambition, funding, and implementation. Spain’s biotech sector shows strong...
New biomarkers and targeted therapies are reshaping the management of kidney damage in autoimmune diseases like lupus and vasculitis. Experts at a Spanish medical meeting highlighted...
EFPIA supports the EU Biotechnology Law and a 12-month SPC extension but warns the current proposal is too limited. A broader scope could attract up to...
German biotech held steady in 2025 but faces ongoing financing pressures, according to EY-Parthenon and BIO Deutschland. Total capital fell 5% to €1.8 billion, with venture...
TG Therapeutics reported strong Phase 1 results for subcutaneous Briumvi in multiple sclerosis, exceeding expectations in bioavailability, safety, and tolerability. The formulation could significantly expand its...
Type 2 diabetes is strongly linked to obesity, and early, strict control may improve outcomes for millions of patients. The SURPASS-EARLY study shows tirzepatide outperforms standard...